- Home
- GWH vs OMGA Comparison
GWH vs OMGA Comparison
Compare GWH & OMGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GWH
- OMGA
- Stock Information
- Founded
- GWH 2011
- OMGA 2017
- Country
- GWH United States
- OMGA United States
- Employees
- GWH N/A
- OMGA N/A
- Industry
- GWH Industrial Machinery/Components
- OMGA Biotechnology: Pharmaceutical Preparations
- Sector
- GWH Miscellaneous
- OMGA Health Care
- Exchange
- GWH Nasdaq
- OMGA Nasdaq
- Market Cap
- GWH 63.2M
- OMGA 53.6M
- IPO Year
- GWH N/A
- OMGA 2021
- Fundamental
- Price
- GWH $5.50
- OMGA $0.47
- Analyst Decision
- GWH Buy
- OMGA Strong Buy
- Analyst Count
- GWH 6
- OMGA 5
- Target Price
- GWH $2.54
- OMGA $9.20
- AVG Volume (30 Days)
- GWH 71.5K
- OMGA 713.1K
- Earning Date
- GWH 03-12-2025
- OMGA 11-14-2024
- Dividend Yield
- GWH N/A
- OMGA N/A
- EPS Growth
- GWH N/A
- OMGA N/A
- EPS
- GWH N/A
- OMGA N/A
- Revenue
- GWH $6,241,000.00
- OMGA $8,095,000.00
- Revenue This Year
- GWH $32.11
- OMGA $181.38
- Revenue Next Year
- GWH $341.09
- OMGA N/A
- P/E Ratio
- GWH N/A
- OMGA N/A
- Revenue Growth
- GWH 31.11
- OMGA 185.04
- 52 Week Low
- GWH $4.35
- OMGA $0.44
- 52 Week High
- GWH $16.50
- OMGA $4.46
- Technical
- Relative Strength Index (RSI)
- GWH 48.82
- OMGA 31.95
- Support Level
- GWH $5.18
- OMGA $0.44
- Resistance Level
- GWH $5.82
- OMGA $0.67
- Average True Range (ATR)
- GWH 0.41
- OMGA 0.09
- MACD
- GWH 0.01
- OMGA -0.01
- Stochastic Oscillator
- GWH 50.08
- OMGA 6.33
About GWH ESS Tech Inc.
ESS Tech Inc is a long-duration energy storage company specializing in iron flow battery technology. The company design and produce long-duration batteries predominantly using earth-abundant materials.
About OMGA Omega Therapeutics Inc.
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using epigenomic controllers, Omega is seeking to transform the practice of human medicine through selective and direct control of the human genome to treat and cure disease. It operates in the U.S.